Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Tilray (TLRY) PT Lowered to $7.40 at Cantor Fitzgerald Ahead of Results
-
Aligos Therapeutics Inc. (ALGS) PT Lowered to $17 at Cantor Fitzgerald After Development Halted on ALG-010133
-
Form N-8A CANTOR FITZGERALD SUSTAI
-
Digital Prime Technologies taps industry vet as COO
-
Form 8-K Cantor Fitzgerald Income For: Jan 01
-
Aytu BioScience's (AYTU) Experienced CFO Hire is a Positive For the Company - Cantor Fitzgerald
-
Biohaven Pharmaceutical Holding (BHVN) Likely to Pre-Release NURTEC-OTD Sales - Cantor Fitzgerald
-
Curaleaf (CURLF) PT Lowered to $16.50 at Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Starts Riot Blockchain (RIOT) at Overweight
-
Blockchain Coinvestors Acquisition Corp. I Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing December 31, 2021
-
Innovative International Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants
-
Semper Paratus Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants
-
Alnylam Pharma (ALNY), Horizon Therapeutics (HZNP) and Mirati Therapeutics (MRTX) Are 2022 Top M&A Targets - Cantor Fitzgerald
-
'Best-Case Exit Strategy': Biogen (BIIB) Stock Falls as Takeover Rumor Denied, But Analysts Bullish on Takeover Prospect
-
Pre-Open Stock Movers 12/29: (TSP) (DNAY) (ORTX) Higher; (MFIN) (FCEL) (RIVN) Lower (more...)
-
Cantor Fitzgerald Assumes Orchard Therapeutics (ORTX) at Overweight, $9 PT
-
Cantor Initiates Brooklyn ImmunoTherapeutics Inc (BTX) at Overweight
-
Satellogic Announces Development of High-Throughput Manufacturing Plant in the Netherlands
-
VYNE Therapeutics (VYNE) and Ardelyx (ARDX) Top Cantor Fitzgerald's Most Shorted Biotech List
-
Form SC 13G EVe Mobility Acquisition Filed by: CANTOR FITZGERALD SECURITIES
-
Intelligent Medicine Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing December 27, 2021
-
U.S. authorizes Merck pill as second at-home COVID-19 treatment
-
Legends of Bezogia Announces Cryptocurrency Key Sponsorship of Dubai Globe Soccer Awards
-
US Authorizes Pfizer's (PFE) Oral COVID-19 Treatment, At-home Use Pill is a 'Game-Changer' Says Analyst
-
Horizonte Minerals PLC Announces Completion of Fundraise
-
Satellogic Announces Upcoming Appointment of Six New Board Members
-
Jaguar Health's (JAGX) Recent Approval Underscores that Portfolio and Execution are Underappreciated - Cantor Fitzgerald
-
Form 4 CF Acquisition Corp. For: Dec 20 Filed by: CANTOR FITZGERALD, L. P.
-
Aridis' (ARDS) Omicron Data is Positive, Reiterates Belief that Pipeline is Undervalued - Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades Arena Pharma (ARNA) to Neutral
-
CF Acquisition Corp. VII Announces Closing of $182.5 Million Initial Public Offering
-
Intra-Cellular Therapies (ITCI) PT Raised to $62 at Cantor Fitzgerald on FDA Approval
-
Mondee To Go Public Through Business Combination with ITHAX Acquisition Corporation (ITHX)
-
Mondee, the Technology-First, Fast Growing Travel Market Disruptor, To Go Public Through Business Combination with ITHAX Acquisition Corporation
-
Mondee, the Technology-First, Fast Growing Travel Market Disruptor, To Go Public Through Business Combination with ITHAX Acquisition Corporation
-
EVe Mobility Acquisition Corp Announces Closing of Upsized $250 Million Initial Public Offering
-
EVe Mobility Acquisition Corp Announces Closing of Upsized $250 Million Initial Public Offering
-
Battery Future Acquisition Corp. Announces Full Exercise of Over-Allotment Option and Closing of $345 Million Initial Public Offering
-
Arbor Rapha Capital Bioholdings Corp. I Announces the Separate Trading of its Shares of Class A Common Stock and Redeemable Warrants Commencing December 20, 2021
-
Abeona Therapeutics (ABEO) Prices 44.7M Stock and Warrant Offering at $0.39/sh
-
Abeona Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants
-
Abeona Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants
-
Rezolve to go Public Via Merger with Armada Acquisition Corp. I (AACIU) in $2B Deal
-
Armada Acquisition Corp. I to acquire Rezolve Mobile Engagement Platform in $2bn deal
-
Armada Acquisition Corp. I to acquire Rezolve Mobile Engagement Platform in $2bn deal
-
Cantor Fitzgerald Starts Cardiol Therapeutics (CRDL) at Overweight
-
Abeona Therapeutics (ABEO) to Offer Common Stock and Warrants
-
Abeona Therapeutics Announces Public Offering of Common Stock and Warrants
-
Abeona Therapeutics Announces Public Offering of Common Stock and Warrants
-
Form 424B3 Cantor Fitzgerald Income

